Latest News Archive
Please select Category, Year, and then Month to display items
02 April 2025
|
Story Nomonde Mbadi
|
Photo Supplied
We wish to inform you of a technical challenge that has affected the performance of our Online Application portal since its opening on 1 April 2025. In close collaboration with our ICT department, the Directorate of the Registrar is actively working to address these issues to restore optimal functionality.
We understand the importance of this system for our prospective applicants and are committed to resolving the challenges swiftly. Your patience and understanding during this period is greatly appreciated.
Should you receive queries regarding this matter, please advise stakeholders that our team is fully engaged in rectifying the situation; we are optimistic about a timely resolution.
Thank you for your continued support and cooperation.
Director: Student Recruitment Services
Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS
Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.
He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.
Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.
The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.
Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.
“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.
“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.